Marine Drugs — Open Access Journal

Marine Drugs (ISSN 1660-3397; CODEN: MDARE6) is the leading open access journal on the research, development, and production of drugs from the sea, including marine natural product chemistry. Marine Drugs is published monthly online by MDPI.

Open Access - free for readers, with publishing fees paid by authors or their institutions.
High visibility: indexed by the Science Citation Index Expanded (Web of Science), PubMed and other databases. Full-text available in PubMed Central.
Rapid publication: manuscripts are peer-reviewed and published within 61 days (average Jan-Jun 2013), accepted papers are immediately published online.

Impact Factor: 3.978 (2012); 5-Year Impact Factor: 3.911 (2012)

Full Imprint Information | Download Journal Flyer

Journal Contact

MDPI AG
Marine Drugs Editorial Office
Klybeckstrasse 64, 4057 Basel, Switzerland
E-Mail: marinedrugs@mdpi.com
Tel. +41 61 683 77 34; Fax: +41 61 302 89 18
Click here to see the full Editorial Board
Click here to see Contact Details

Forthcoming Special Issues

Advances in Marine Chitin and Chitosan (Guest Editors: David Harding, Hitoshi Sashiwa)
Alkaloid Analogs (Guest Editor: Sadanandan Velu)
Bioactive Compounds from Marine Invertebrates (Guest Editor: Kirsten Benkendorff)
Bioactive Compounds from Marine Microbes (Guest Editor: Kirk Gustafson)
Bioactive Halogenated Metabolites of Marine Origin (Guest Editor: Vassilios Roussis)
Emerging Marine Toxins (Guest Editor: Vítor Vasconcelos)
Marine Biomaterials (Guest Editor: Hermann Ehrlich)
Marine Carotenoids (Guest Editors: Kazuo Miyashita, Takashi Maoka)
Marine Dinoflagellates (Guest Editor: Andrea Bourdelais)
Marine Functional Food Products - Cardiovascular Diseases (Guest Editor: Constantina Nasopoulou)
Metabolomics - Applications in Marine Natural Products Chemistry (Guest Editors: Daniel Dias, Ute Roessner)
Synthesis around Marine Natural Products (Guest Editor: Yoshihide Usami)
Terpenoids of Marine Origin (Guest Editor: RuAngelie Edrada-Ebel)

Mar. Drugs EISSN 1660-3397 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert